What the six lenses say about POLYMED — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How POLYMED’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +0.4pp | -2.1pp | +3.0pp | +20.2pp | +28.2pp | -11.7pp |
Nifty 500 Broad-market baseline | +0.3pp | -2.1pp | +1.9pp | +18.6pp | +22.4pp | -16.9pp |
Sector Own-sector index | — | — | +0.6pp | +15.9pp | +13.8pp | -30.2pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
POLYMED daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
POLYMED ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 385 | 420 | 424 | 441 | 403 | 444 | 494 | 535 |
| ↳ change QoQ | — | +9.2% | +1.0% | +4.0% | -8.6% | +10.2% | +11.3% | +8.3% |
| EBITDA (₹cr) | 121 | 141 | 136 | 119 | 106 | 115 | 111 | 110 |
| EBITDA margin | 31.4% | 33.7% | 32.1% | 27.0% | 26.3% | 25.9% | 22.5% | 20.6% |
| PAT (₹cr) | 74 | 87 | 85 | 92 | 93 | 92 | 71 | 65 |
| ↳ change QoQ | — | +18.1% | -2.5% | +7.9% | +1.1% | -1.1% | -22.8% | -8.5% |
| Net margin | 19.2% | 20.8% | 20.1% | 20.9% | 23.1% | 20.7% | 14.4% | 12.2% |
| EPS (₹) | 7.71 | 9.01 | 8.48 | 9.06 | 9.19 | 9.06 | 7.00 | 6.54 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding POLYMED (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Quant Small Cap Gr | 2.18% | 34,069 | |
| UTI Flexi Cap Reg Gr | 1.00% | 24,036 | |
| HSBC Midcap Gr | 0.96% | 15,578 | |
| Invesco India largecap Gr | 1.53% | 11,746 | |
| WhiteOak Capital Flexi Cap Reg Gr | 0.62% | 9,136 | |
| Quant Multi Cap Gr | 0.58% | 7,717 | |
| SBI Healthcare Opportunities Reg Gr | 2.02% | 5,400 | |
| WhiteOak Capital Multi Cap Reg Gr | 0.60% | 4,134 | |
| WhiteOak Capital Phrm and Hlthcr Reg Gr | 0.91% | 825 | |
| WhiteOak Capital ELSS Tax Saver DirGr | 0.73% | 494 |
ETFs holding POLYMED (0)
No tracked ETF holds POLYMED ≥0.5%.